| Value | ₹100.0 Cr |
|---|
NSE filing, NSE: BLISSGVS. Summary written from the filing by ALFA Finder's alert engine.
Bliss GVS Pharma Ltd: key numbers
- Share price
- ₹647.50
- Market cap
- ₹6,888 Cr
- Revenue (annual)
- ₹927.1 Cr
- Net profit (annual)
- ₹129.1 Cr
- P/E (TTM)
- 42.7×Sector 48.7×
- Promoter holding
- 50.07%+15.06% QoQ
- FII holding
- 5.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bliss GVS Pharma Ltd
All →Bliss GVS Pharma Q2 FY27 Results: Net Profit ₹53.3 Cr, Up 86.4% YoY
Bliss GVS Pharma Ltd reported revenue from operations of ₹313.4 Cr (+28.2% YoY) and net profit of ₹53.3 Cr (+86.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹53.3 Cr · +86.4% YoY
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bliss GVS Pharma Board Meeting Date
Bliss GVS Pharma Ltd scheduled a board meeting for October 29, 2026, to approve the company's unaudited financial results for the quarter ending September 30, 2026.
Bliss GVS Pharma Other Announcement
Bliss GVS Pharma Ltd has filed its quarterly shareholding pattern report for the period ended September 30, 2026.
Bliss GVS Pharma Annual General Meeting
Bliss GVS Pharma has issued a postal ballot notice to seek member approval for the appointment of three directors. This follows a recent change in control.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma Limited allotted 53,500 equity shares under its Employee Stock Option Plan (ESOP). This issuance increases the company's total paid-up share capital.
Other credit rating announcements
All →Mangalam Global Enterprise Credit Rating
Infomerics reaffirmed Mangalam Global's IVR BBB rating, revised outlook to Negative and moved it to Issuer Not Cooperating. Rating action dated 29 October 2026.
DCM Shriram Credit Rating
DCM Shriram reaffirmed ICRA ratings on its long-term and short-term bank facilities and fixed deposit programme. Commercial paper rating was reaffirmed and withdrawn, with no change in rating levels.
Oil And Natural Gas Corporation Credit Rating
ONGC's debt instruments were affirmed at IND AAA/Stable by India Ratings. The affirmation covers bank loans, commercial papers and non-convertible debentures.
Regency Fincorp Credit Rating
Infomerics reaffirmed Regency Fincorp's IVR BBB/Stable rating on its NCDs and bank facilities. The rating covers Rs 650 Crore of instruments and is valid until July 16, 2027.
Borosil Renewables Credit Rating
Borosil Renewables had its bank loan rating upgraded to IND AA-/Stable/IND A1+ by India Ratings. Proposed bank facilities of Rs 450 million were assigned the same rating.
Singer India Credit Rating
Singer India's Rs.45 Crore bank facilities were re-rated by CRISIL. Long-term stayed BBB-/Stable while the short-term rating was upgraded to Crisil A3+.